{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "APVO",
        "Security_Name": "Aptevo Therapeutics Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "S",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "D",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "APVO",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 0,
                "buy": 2,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 0,
                "buy": 2,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 2.25,
        "open": 2.24,
        "dayLow": 2.13,
        "dayHigh": 2.315,
        "regularMarketPreviousClose": 2.25,
        "regularMarketOpen": 2.24,
        "regularMarketDayLow": 2.13,
        "regularMarketDayHigh": 2.315,
        "payoutRatio": 0,
        "beta": 5.518054,
        "forwardPE": -0.4152381,
        "volume": 139586,
        "regularMarketVolume": 139586,
        "averageVolume": 767461,
        "averageVolume10days": 154490,
        "averageDailyVolume10Day": 154490,
        "bid": 2.18,
        "ask": 2.25,
        "bidSize": 1200,
        "askSize": 1000,
        "marketCap": 10677706,
        "fiftyTwoWeekLow": 1.94,
        "fiftyTwoWeekHigh": 7.64,
        "priceToSalesTrailing12Months": 1.0812867,
        "fiftyDayAverage": 2.79526,
        "twoHundredDayAverage": 3.78382,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2021",
                    "actual": -1.43,
                    "estimate": -1.47
                },
                {
                    "date": "4Q2021",
                    "actual": -1.27,
                    "estimate": -1.29
                },
                {
                    "date": "1Q2022",
                    "actual": -1.55,
                    "estimate": -1.15
                },
                {
                    "date": "2Q2022",
                    "actual": 5.58,
                    "estimate": -1.33
                }
            ],
            "currentQuarterEstimate": -1.64,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1604966400
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 23067000,
                    "earnings": -53689000
                },
                {
                    "date": 2019,
                    "revenue": 0,
                    "earnings": -40448000
                },
                {
                    "date": 2020,
                    "revenue": 4309000,
                    "earnings": -17750000
                },
                {
                    "date": 2021,
                    "revenue": 12292000,
                    "earnings": -28457000
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 3096000,
                    "earnings": -6997000
                },
                {
                    "date": "4Q2021",
                    "revenue": 3665000,
                    "earnings": -6272000
                },
                {
                    "date": "1Q2022",
                    "revenue": 3114000,
                    "earnings": -7697000
                },
                {
                    "date": "2Q2022",
                    "revenue": 0,
                    "earnings": 28010000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1604966400
            ],
            "earningsAverage": -1.64,
            "earningsLow": -1.76,
            "earningsHigh": -1.52
        },
        "dividendDate": "2020-03-27T00:00:00.000Z"
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-05-13T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-05-28T00:00:00.000Z",
                "firm": "Roth Capital",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-11-11T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2018-04-11T00:00:00.000Z",
                "firm": "Roth Capital",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2016-09-09T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "postMarketChangePercent": 0.02752291,
        "postMarketChange": 0.059999943,
        "postMarketTime": "2023-01-07T00:59:11.000Z",
        "postMarketPrice": 2.24,
        "postMarketSource": "DELAYED",
        "regularMarketChangePercent": -0.031111084,
        "regularMarketChange": -0.06999993,
        "regularMarketTime": "2023-01-06T20:59:32.000Z",
        "priceHint": 4,
        "regularMarketPrice": 2.18,
        "regularMarketDayHigh": 2.315,
        "regularMarketDayLow": 2.13,
        "regularMarketVolume": 139586,
        "averageDailyVolume10Day": 154490,
        "averageDailyVolume3Month": 767461,
        "regularMarketPreviousClose": 2.25,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 2.24,
        "exchange": "NCM",
        "exchangeName": "NasdaqCM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "APVO",
        "underlyingSymbol": null,
        "shortName": "Aptevo Therapeutics Inc.",
        "longName": "Aptevo Therapeutics Inc.",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 10677706
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": -3460974,
        "forwardPE": -0.31142858,
        "profitMargins": 0.71332,
        "floatShares": 5031491,
        "sharesOutstanding": 4898030,
        "sharesShort": 56997,
        "sharesShortPriorMonth": 42348,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.0112,
        "heldPercentInsiders": 0.01118,
        "heldPercentInstitutions": 0.16007,
        "shortRatio": 1.24,
        "shortPercentOfFloat": 0.0113,
        "beta": 5.518054,
        "category": null,
        "bookValue": 3.762,
        "priceToBook": 0.579479,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": 6312000,
        "trailingEps": -5.235,
        "forwardEps": -5.25,
        "lastSplitFactor": "1:14",
        "lastSplitDate": "2020-03-27T00:00:00.000Z",
        "enterpriseToRevenue": -0.35,
        "enterpriseToEbitda": 0.166
    },
    "summaryProfile": {
        "address1": "2401 4th Avenue",
        "address2": "Suite 1050",
        "city": "Seattle",
        "state": "WA",
        "zip": "98121",
        "country": "United States",
        "phone": "206 838 0500",
        "fax": "206 838 0503",
        "website": "https://www.aptevotherapeutics.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.",
        "fullTimeEmployees": 54,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 2.18,
        "targetHighPrice": 23,
        "targetLowPrice": 13,
        "targetMeanPrice": 18,
        "targetMedianPrice": 18,
        "recommendationMean": 2,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 2,
        "totalCash": 29431000,
        "totalCashPerShare": 5.781,
        "ebitda": -20894000,
        "totalDebt": 10749000,
        "quickRatio": 4.203,
        "currentRatio": 4.484,
        "totalRevenue": 9875000,
        "debtToEquity": 46.639,
        "revenuePerShare": 1.999,
        "returnOnAssets": -0.24896,
        "returnOnEquity": 0.34185,
        "grossProfits": 12292000,
        "freeCashflow": -22035876,
        "operatingCashflow": -17309000,
        "grossMargins": 1.13701,
        "ebitdaMargins": -2.11585,
        "operatingMargins": -2.2241,
        "profitMargins": 0.71332,
        "financialCurrency": "USD"
    }
}